Literature DB >> 19322822

Repair of segmental bone-defect of goat's tibia using a dynamic perfusion culture tissue engineering bone.

Chaofeng Wang1, Zhen Wang, Aimin Li, Feng Bai, Jianxi Lu, Shanglong Xu, Dichen Li.   

Abstract

Segmental bone defect resulted from trauma or excision of bone tumor or pathology represents a common and significant clinical problem. In an attempt to solve this dilemma, we use beta-TCP combined with autologous bone marrow mesenchymal stem cells (auto-BMSC) and cultured by dynamic perfusion to repair the segmental bone defects of goat's tibia. The beta-TCP scaffolds combined with auto-BMSC by dynamic perfusion bioreactor or in static state were respectively transplanted into the defect (30 mm) of the goat tibias. The X-ray films were gathered and analyzed at the different time points. At 24 weeks post-operation, tissue engineering bones implanted were analyzed by histology and Micro-CT. Results show that the capacity of osteogenesis in experimental group was higher than that of control group by X-ray, histological, and micro-CT analysis (p < 0.05). According to the study, we found that repair for segmental bone defects of tissue engineering bone cultured by dynamic perfusion culture bioreactor outweigh those cultured in static state. And we can conclude that this technology of tissue engineering bone will become a clinical method to the segmental bone-defects repair in the future. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19322822     DOI: 10.1002/jbm.a.32347

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  8 in total

1.  Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo.

Authors:  Franz Josef Gildehaus; Florian Haasters; Inga Drosse; Erika Wagner; Christian Zach; Wolf Mutschler; Paul Cumming; Peter Bartenstein; Matthias Schieker
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

2.  In vivo bone regeneration using tubular perfusion system bioreactor cultured nanofibrous scaffolds.

Authors:  Andrew B Yeatts; Sanne K Both; Wanxun Yang; Hamdan S Alghamdi; Fang Yang; John P Fisher; John A Jansen
Journal:  Tissue Eng Part A       Date:  2013-08-31       Impact factor: 3.845

3.  Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta.

Authors:  Feng Li; Xujun Wang; Christopher Niyibizi
Journal:  Bone       Date:  2010-06-04       Impact factor: 4.398

4.  Integration of a novel injectable nano calcium sulfate/alginate scaffold and BMP2 gene-modified mesenchymal stem cells for bone regeneration.

Authors:  Xiaoning He; Rosemary Dziak; Keya Mao; Robert Genco; Mark Swihart; Mark Swithart; Chunyi Li; Shuying Yang
Journal:  Tissue Eng Part A       Date:  2012-11-16       Impact factor: 3.845

Review 5.  Animal models for bone tissue engineering and modelling disease.

Authors:  Jacqui Anne McGovern; Michelle Griffin; Dietmar Werner Hutmacher
Journal:  Dis Model Mech       Date:  2018-04-23       Impact factor: 5.758

6.  Segmental Additive Tissue Engineering.

Authors:  Martina Sladkova; Rawan Alawadhi; Rawan Jaragh Alhaddad; Asmaa Esmael; Shoug Alansari; Munerah Saad; Jenan Mulla Yousef; Lulwa Alqaoud; Giuseppe Maria de Peppo
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

Review 7.  Recent Advances in Mechanically Loaded Human Mesenchymal Stem Cells for Bone Tissue Engineering.

Authors:  Kar Wey Yong; Jane Ru Choi; Jean Yu Choi; Alistair C Cowie
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 8.  Novel Techniques and Future Perspective for Investigating Critical-Size Bone Defects.

Authors:  Elijah Ejun Huang; Ning Zhang; Huaishuang Shen; Xueping Li; Masahiro Maruyama; Takeshi Utsunomiya; Qi Gao; Roberto A Guzman; Stuart B Goodman
Journal:  Bioengineering (Basel)       Date:  2022-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.